Status:

COMPLETED

Cryoneurolysis for the Management of Chronic Pain in Patients With Knee Osteoarthritis

Lead Sponsor:

Esbjerg Hospital - University Hospital of Southern Denmark

Collaborating Sponsors:

Odense University Hospital

Conditions:

Chronic Pain

Osteoarthritis, Knee

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Pain is the principal symptom in knee osteoarthritis (OA) and results in a considerable amount of years lived with disability, emotional distress and has significant socioeconomic consequences. Conser...

Detailed Description

BACKGROUND Pain is the principal symptom in knee osteoarthritis (OA) and results in a considerable amount of years lived with disability, emotional distress and has significant socioeconomic consequen...

Eligibility Criteria

Inclusion

  • Referred to GLA:D by a physician.
  • Age ≥ 18y
  • Chronic knee pain for a minimum duration of 6 months.
  • Pain intensity ≥ 40mm on a 100mm visual analogue scale (VAS).
  • Radiographic confirmation of osteoarthritis; Grade 2-4 changes according to the Kellgren Lawrence classification system
  • A decrease of ≥ 50 % in VAS scores with diagnostic genicular nerve block.
  • Written and oral understanding of Danish.

Exclusion

  • History of systemic inflammatory conditions such as rheumatoid arthritis.
  • Previous recipient of cryoneurolysis for the knee.
  • Use of hyaluronic acid within the previous 30 days.
  • Injection of corticosteroid within the previous 3 months.
  • Clinical significant structural abnormities affecting locomotion and knee function aside from osteoarthritis and which might cause chronic knee pain.
  • Body mass index ≥ 18 and ≤ 40 kg/m
  • In treatment for other pain conditions.
  • Pregnancy
  • Coagulopathy
  • Uncontrolled serious disease (cancer, diabetes, etc.)
  • Disease associated with reactions to cold, such as cryoglobulinemia, cold urticarial and Renaud's syndrome.

Key Trial Info

Start Date :

June 26 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2023

Estimated Enrollment :

87 Patients enrolled

Trial Details

Trial ID

NCT03774121

Start Date

June 26 2019

End Date

March 1 2023

Last Update

October 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital of Southwest Jutland

Esbjerg, Region Syddanmark, Denmark, 6700